Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | STK17B | O94768 | 1/20 | 0.41 |
| ▸ | STK17A | Q9UEE5 | 1/20 | 0.41 |
| ▸ | BRD4 | O60885 | 14/20 | 0.39 |
| ▸ | ADORA3 | P0DMS8 | 2/20 | 0.37 |
| ▸ | ADORA2A | P29274 | 2/20 | 0.37 |
| ▸ | ADORA1 | P30542 | 2/20 | 0.37 |
| ▸ | MC4R | P32245 | 1/20 | 0.37 |
| ▸ | PIM1 | P11309 | 1/20 | 0.36 |
| ▸ | PIM2 | Q9P1W9 | 1/20 | 0.36 |
| ▸ | ADORA2B | P29275 | 1/20 | 0.36 |
| ▸ | MEN1 | O00255 | 1/20 | 0.36 |
| ▸ | GAA | P10253 | 1/20 | 0.36 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.36 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL23728785 | 0.91 | STK17B (0.40) | STK17BSTK17ABRD4ADORA3ADORA2A | |
| SCHEMBL28984133 | 0.80 | HDAC1 (0.42) | ADORA3 | |
| SCHEMBL23728790 | 0.79 | STK17B (0.48) | STK17BSTK17ABRD4ADORA3ADORA2A | |
| SCHEMBL23728900 | 0.78 | MC4R (0.35) | MC4RMEN1GAAKMT2A | |
| SCHEMBL23728901 | 0.76 | TOP1 (0.33) | MC4R | |
| SCHEMBL31614509 | 0.75 | CA1 (0.54) | ADORA3MEN1GAAKMT2A | |
| SCHEMBL23728754 | 0.74 | P2RX3 (0.42) | MC4RPIM2MEN1KMT2A | |
| Hydrochloric Acid SCHEMBL23728767 | 0.73 | P2RX3 (0.41) | MC4RPIM2MEN1KMT2A | |
| SCHEMBL23728949 | 0.73 | MEN1 (0.33) | MC4RMEN1GAAKMT2A | |
| SCHEMBL3983639 | 0.73 | CA1 (0.45) | ADORA3MEN1GAAKMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4384506-A1 | PROCESS FOR POLYAMIDE SYNTHESIS | Design Therapeutics, Inc. (US) | 2024-06-19 | — | — | EP | disclosed |
| WO-2023014793-A1 | PROCESS FOR POLYAMIDE SYNTHESIS | Design Therapeutics, Inc. (US) | 2023-02-09 | — | — | WO | disclosed |
| EP-4100404-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. (US) | 2022-12-14 | — | — | EP | disclosed |
| WO-2021158707-A1 | METHODS AND COMPOUNDS FOR THE TREATMENT OF GENETIC DISEASE | Design Therapeutics, Inc. (US) | 2021-08-12 | — | — | WO | disclosed |